CNV Radar: an improved method for somatic copy number alteration characterization in oncology

por Soong, David, Stratford, Jeran, Avet-Loiseau, Herve, Bahlis, Nizar, Davies, Faith, Dispenzieri, Angela, Sasser, A. Kate, Schecter, Jordan M., Qi, Ming, Brown, Chad, Jones, Wendell, Keats, Jonathan J., Auclair, Daniel, Chiu, Christopher, Powers, Jason, Schaffer, Michael
Publicado en BMC Bioinformatics (2020)

Inherited determinants of early recurrent somatic mutations in prostate cancer

por Romanel, Alessandro, Garritano, Sonia, Stringa, Blerta, Blattner, Mirjam, Dalfovo, Davide, Chakravarty, Dimple, Soong, David, Cotter, Kellie A., Petris, Gianluca, Dhingra, Priyanka, Gasperini, Paola, Cereseto, Anna, Elemento, Olivier, Sboner, Andrea, Khurana, Ekta, Inga, Alberto, Rubin, Mark A., Demichelis, Francesca
Publicado en Nat Commun (2017)

Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia

por Lamble, Adam J., Kosaka, Yoko, Laderas, Ted, Maffit, Allie, Kaempf, Andy, Brady, Lauren K., Wang, Weiwei, Long, Nicola, Saultz, Jennifer N., Mori, Motomi, Soong, David, LeFave, Clare V., Huang, Fei, Adams, Homer, Loriaux, Marc M., Tognon, Cristina E., Lo, Pierrette, Tyner, Jeffrey W., Fan, Guang, McWeeney, Shannon K., Druker, Brian J., Lind, Evan F.
Publicado en Proc Natl Acad Sci U S A (2020)

Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX

por Dimopoulos, Meletios A., San-Miguel, Jesus, Belch, Andrew, White, Darrell, Benboubker, Lotfi, Cook, Gordon, Leiba, Merav, Morton, James, Ho, P. Joy, Kim, Kihyun, Takezako, Naoki, Moreau, Philippe, Kaufman, Jonathan L., Sutherland, Heather J., Lalancette, Marc, Magen, Hila, Iida, Shinsuke, Kim, Jin Seok, Prince, H. Miles, Cochrane, Tara, Oriol, Albert, Bahlis, Nizar J., Chari, Ajai, O’Rourke, Lisa, Wu, Kaida, Schecter, Jordan M., Casneuf, Tineke, Chiu, Christopher, Soong, David, Sasser, A. Kate, Khokhar, Nushmia Z., Avet-Loisea, Hervé, Usmani, Saad Z.
Publicado en Haematologica (2018)

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

por Spencer, Andrew, Lentzsch, Suzanne, Weisel, Katja, Avet-Loiseau, Hervé, Mark, Tomer M., Spicka, Ivan, Masszi, Tamas, Lauri, Birgitta, Levin, Mark-David, Bosi, Alberto, Hungria, Vania, Cavo, Michele, Lee, Je-Jung, Nooka, Ajay K., Quach, Hang, Lee, Cindy, Barreto, Wolney, Corradini, Paolo, Min, Chang-Ki, Scott, Emma C., Chanan-Khan, Asher A., Horvath, Noemi, Capra, Marcelo, Beksac, Meral, Ovilla, Roberto, Jo, Jae-Cheol, Shin, Ho-Jin, Sonneveld, Pieter, Soong, David, Casneuf, Tineke, Chiu, Christopher, Amin, Himal, Qi, Ming, Thiyagarajah, Piruntha, Sasser, A. Kate, Schecter, Jordan M., Mateos, Maria-Victoria
Publicado en Haematologica (2018)